Company Overview

CLIA-certified laboratory focused on immunoassays


ProterixBio is a high-complexity CLIA-certified clinical testing laboratory (licensed in all 50 States).

ProterixBio has expert level quantitative immunoassay development and validation capabilities. Over the last several years, ProterixBio’s assay development team has developed and validated over 30 quantitative immunoassays. In addition to developing and validating assays for serum and plasma, ProterixBio has developed assays using dried blood spot specimens. Please contact us for more information on our bespoke immunoassay development and validation services. 

We develop and commercialize diagnostic solutions that address critical unmet needs in population health and chronic care. An area of focus has been vulnerable populations such as those with chronic obstructive pulmonary disease, diabetes and cardiovascular disease.

The company has developed algorithms utilizing combinations of blood-based biomarkers for identifying individuals at high risk for severe outcomes. ProterixBio maintains a rigorous approach to test development that includes collaborating with leading academic medical centers and validating assays in large, carefully curated cohorts.


Learn about ProterixBio’s Platform

Assay Development Services for Decentralized Clinical Trials

To learn more about ProterixBio: